Literature DB >> 22669250

[Partial nephrectomy. Rationale and limitations of an organ-preserving approach].

J Casuscelli1, C Gratzke, C G Stief, M Staehler.   

Abstract

The rising incidence of renal cell cancer in recent decades has led to a revision in the therapy of this malignancy. For small renal masses, partial nephrectomy has become the standard surgical treatment instead of radical nephrectomy. This approach can lead to a higher overall survival due to preservation of renal function. Avoiding chronic kidney disease is mandatory for patients with benign or small non-aggressive tumors; however, partial nephrectomy correlates with higher complication rates and is conditioned by operator skills. The role of partial nephrectomy compared to radical nephrectomy is still to be established particularly for larger tumors. The results of studies so far are mostly based on non-randomized retrospective data. This article will present the pros and cons of partial nephrectomy and will focus on the steps required to promulgate the indications of nephron-sparing surgery.

Entities:  

Mesh:

Year:  2012        PMID: 22669250     DOI: 10.1007/s00120-012-2873-y

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  32 in total

1.  A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.

Authors:  Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Marc Colombel; Laurence Klotz; Eila Skinner; Thomas Keane; Sandrine Marreaud; Sandra Collette; Richard Sylvester
Journal:  Eur Urol       Date:  2010-12-22       Impact factor: 20.096

2.  Renal cell carcinoma: prognostic significance of incidentally detected tumors.

Authors:  K H Tsui; O Shvarts; R B Smith; R Figlin; J B de Kernion; A Belldegrun
Journal:  J Urol       Date:  2000-02       Impact factor: 7.450

3.  Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome.

Authors:  James McKiernan; Ofer Yossepowitch; Michael W Kattan; Rachel Simmons; Robert J Motzer; Victor E Reuter; Paul Russo
Journal:  Urology       Date:  2002-12       Impact factor: 2.649

4.  A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.

Authors:  Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Jean-Marie Marechal; Laurence Klotz; Eila Skinner; Thomas Keane; Ilse Claessens; Richard Sylvester
Journal:  Eur Urol       Date:  2006-11-15       Impact factor: 20.096

5.  Rising incidence of small renal masses: a need to reassess treatment effect.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

6.  Every minute counts when the renal hilum is clamped during partial nephrectomy.

Authors:  R Houston Thompson; Brian R Lane; Christine M Lohse; Bradley C Leibovich; Amr Fergany; Igor Frank; Inderbir S Gill; Michael L Blute; Steven C Campbell
Journal:  Eur Urol       Date:  2010-06-09       Impact factor: 20.096

7.  Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.

Authors:  Karim Bensalah; Allan J Pantuck; Nathalie Rioux-Leclercq; Rodolphe Thuret; Francesco Montorsi; Pierre I Karakiewicz; Nicolas Mottet; Laurent Zini; Roberto Bertini; Laurent Salomon; Arnaud Villers; Michel Soulie; Laurent Bellec; Pascal Rischmann; Alexandre De la Taille; Raffi Avakian; Maxime Crepel; Jean-Marie Ferriere; Jean-Christophe Bernhard; Thierry Dujardin; Frédéric Pouliot; Jérôme Rigaud; Christian Pfister; Baptiste Albouy; Laurent Guy; Steven Joniau; Hendrik van Poppel; Thierry Lebret; Thibault Culty; Fabien Saint; Amnon Zisman; Orit Raz; Hervé Lang; Romain Spie; Andreas Wille; Jan Roigas; Alfredo Aguilera; Bastien Rambeaud; Luis Martinez Piñeiro; Ofer Nativ; Roy Farfara; François Richard; Morgan Roupret; Christian Doehn; Patrick J Bastian; Stefan C Muller; Jacques Tostain; Arie S Belldegrun; Jean-Jacques Patard
Journal:  Eur Urol       Date:  2009-03-31       Impact factor: 20.096

8.  Solid renal tumors: an analysis of pathological features related to tumor size.

Authors:  Igor Frank; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

Review 9.  The expanding role of partial nephrectomy: a critical analysis of indications, results, and complications.

Authors:  Karim Touijer; Didier Jacqmin; Louis R Kavoussi; Francesco Montorsi; Jean Jacques Patard; Craig G Rogers; Paul Russo; Robert G Uzzo; Hendrik Van Poppel
Journal:  Eur Urol       Date:  2009-10-20       Impact factor: 20.096

10.  Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality.

Authors:  Mike M Nguyen; Inderbir S Gill
Journal:  J Urol       Date:  2009-01-16       Impact factor: 7.450

View more
  2 in total

1.  [Postoperative prognosis of chromophobic renal cell carcinoma: comparative analysis of the multinational CORONA database].

Authors:  M May; R Zigeuner; A Aziz; L Cindolo; C Gilfrich; L Schips; O De Cobelli; B Rocco; C De Nunzio; A Tubaro; I Coman; B Feciche; M Truss; B Hoschke; O Dalpiaz; A Stoltze; F Fenske; H-M Fritsche; T Chromecki; S Lebentrau; R S Figenshau; K Madison; M Sánchez-Chapado; M Del Carmen Santiago Martin; L Salzano; G Lotrecchiano; S Joniau; R Waidelich; C G Stief; S Brookman-May
Journal:  Urologe A       Date:  2014-02       Impact factor: 0.639

2.  [Indications for nephron-sparing surgery. Analysis over a 13-year period in the context of changing guidelines].

Authors:  P J Olbert; M Maier; H Heers; A Hegele; R Hofmann
Journal:  Urologe A       Date:  2015-06       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.